Studies โ€บ Sample & attrition ยท Last reviewed 2026-05-16

Sample size and attrition

Summary

The main Dutch outcome study (de Vries 2014) describes 55 of the 70 young people followed in the first study (2011): 15 fewer, approximately 21%. Of the 15, it is documented that one participant died after surgery. Whether attrition was at-random or differential remains a methodological concern.

1. Attrition flow de Vries 2014

MomentnLoss between measurements
T0 โ€” start GnRHa70โ€”
T1 โ€” start CSH70None: all 70 started cross-sex hormones (source)
T2 โ€” 1 yr post-op5515 fewer than at T1, including one participant who died

2. Nature of attrition

  • One participant died from necrotising fasciitis after vaginoplasty (source).

3. Effect on outcome measures

Biggs (2023) writes that the favourable outcomes of the Dutch study rested on a small number of observations (source). If attrition is selective, for example because poorer-functioning participants are measured less often, T2 figures could overestimate the actual outcome; that is a possible mechanism, not an established fact. See /evaluations/biggs-puberty-blocker-overview/.1

4. Broader context

The Dutch Health Council (Gezondheidsraad) writes in its advice of 30 June 2026 that many studies have substantial participant attrition and limited follow-up, so that figures on stopping, regret or detransition cannot be established reliably (source). See also replication attempts.2

See also

Footnotes

  1. Biggs M. The Dutch Protocol for juvenile transsexuals: origins and evidence. J Sex Marital Ther. 2023;49(4):348โ€“68.
  2. Gezondheidsraad. Transgenderzorg voor jongeren. Advice, 30 June 2026.